MIRA INFORM
REPORT
|
Report Date : |
31.01.2011 |
IDENTIFICATION DETAILS
|
Name : |
FESTEL LABORATORIES |
|
|
|
|
Registered Office : |
Link |
|
|
|
|
Country : |
|
|
|
|
|
Year of Establishment : |
2008 |
|
|
|
|
Legal Form : |
Partnership Concern |
|
|
|
|
Line of Business : |
Manufacture &
Marketing of Pharmaceutical Products |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
b2 |
b2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Business Name
FESTEL LABORATORIES
Full Address
|
Registered Address
& Factory |
|
Link |
|
Tel # |
92
(42) 35420919, 35423433, 37532759,
37532773 |
|
Fax # |
92 (42)
35432482 |
Short Description Of Business
|
a. |
Nature of Business |
Manufacture & Marketing of
Pharmaceutical Products |
|
b. |
Year Established |
2008 |
Branches
None
Legal Status
Subject Concern was established as a Partnership business in 2008
Details of Managing Partner /
Partners
|
Names |
Nationality |
Address |
Occupation |
Designation |
|
Mr. Amir Jahangir Mr. Azam Jahangir |
Pakistani Pakistani |
Link Link |
Business Business |
Managing Partner Partner |
Associates
A. Subsidiary
None
B. Associated
Companies
(1) Apex Pharmaceuticals,
Products
(1) Subject Concern
is engaged in manufacture & marketing of Pharmaceutical Products.
(2) It purchases raw material against D/A, D/P basis
(3) It sells against Cash / Credit terms to its local customers.
(4) Its’ major customers are mainly Distributors, Pharmacies etc.
(5) Subject operates from caption leased factory premises situated at industrial area.
(6) Subject employs about 40 persons in its set up.
Annual Sales Volume
|
Year |
In Pak Rupees |
|
2010 |
5,000,000/- (Estimated) |
Capacity & Production
The capacity and production of the concern ’s plant is indeterminable as it is multi- product and involves various processes of manufacture.
Bankers
(1)
Habib Metropolitan
Bank Limited,
(2)
MCB Bank
Limited,
(3)
United Bank
Limited,
(4)
Bank Alfalah
Limited,
Foreign Exchange Rates
|
Currency |
Unit |
Pakistani Rupee |
|
US Dollar |
1 |
Rs. 86.00 |
|
|
1 |
Rs. 136.38 |
|
Euro |
1 |
Rs. 116.81 |
Comments
Subject Concern was established in 2008 and is engaged in
manufacture & marketing of Pharmaceutical Products. Trade relations are not
known. Concern is new in this business. Such
as conducting business activity with the subject is considered to be a trade
risk.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.74 |
|
|
1 |
Rs.72.73 |
|
Euro |
1 |
Rs.62.73 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.